Last reviewed · How we verify
Phytolacca decandra
Phytolacca decandra (pokeweed) is a botanical preparation that stimulates immune function and has been traditionally used for its anti-inflammatory and lymphatic system-supporting properties.
Phytolacca decandra (pokeweed) is a botanical preparation that stimulates immune function and has been traditionally used for its anti-inflammatory and lymphatic system-supporting properties. Used for Lymphatic system support and immune stimulation (traditional/homeopathic use).
At a glance
| Generic name | Phytolacca decandra |
|---|---|
| Also known as | homeopathic medicine |
| Sponsor | Universidade Federal do Rio de Janeiro |
| Drug class | Botanical/Herbal preparation |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Phytolacca decandra contains bioactive compounds including lectins and polysaccharides that are believed to enhance immune cell activation and proliferation. The preparation has been used in traditional and homeopathic medicine to support lymphatic drainage and reduce inflammatory responses, though its precise molecular mechanisms in humans remain incompletely characterized.
Approved indications
- Lymphatic system support and immune stimulation (traditional/homeopathic use)
Common side effects
- Gastrointestinal irritation
- Nausea
- Allergic reactions
Key clinical trials
- Poke and a Placebo (NA)
- A Study of Metabolic Agents Following Brain Radiation
- Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial (NA)
- Exploring Paraspinal Electromyographic Features in Adolescent Idiopathic Scoliosis Patients
- Combined Effects of Visceral Manipulation and Noble Technique on Post-partum Females With Diastasis Recti (NA)
- Comparative Effects of Wurn Technique and Mercier Therapy in Women With Endometriosis (NA)
- Continuous Glucose Monitoring for Women With Diabetes Mellitus in the Intrapartum and Postpartum Inpatient Care
- Efficacy of Social Cognitive Training (SCT) in Recent-onset Psychosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phytolacca decandra CI brief — competitive landscape report
- Phytolacca decandra updates RSS · CI watch RSS
- Universidade Federal do Rio de Janeiro portfolio CI